PIK3CA and gastric neoplasm: These dual PI3K/mTOR inhibitors have been shown to enhance 5-FU cytotoxicity both in vitro and in vivo [115], especially in PI3KCA mutant gastric tumor cells which are thought to be secondary to cellular heterogeneity in regard to sensitivity to PI3K and mTOR inhibition [116].